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Abstract
Background: We analyse magnesium levels in amniotic fluid to establish normal values for the 14
th to 18
th week
of pregnancy and establish critical values that could be useful diagnostic and therapeutic guidelines for possible
complications.
Findings: Ninety-two samples of amniotic fluid obtained by amniocentesis as well as the corresponding serum
samples of pregnant women were analysed. The gestational age (mean ± SD) at which the amniotic fluid sample
was obtained was 16.13 ± 1.87 weeks. Magnesium levels were determined by colorimetric assay with
chlorophosphonazo-III using the the Cobas c 501 analyser (Roche Diagnostics). Statistical treatment of data was
performed using the SPSS program, version 15.0.
Results revealed a mean magnesium value of 1.65 ± 0.16 mg/dL in amniotic fluid and 1.97 ± 0.23 mg/dL in serum.
Conclusions: It would be interesting to extend the study to a larger number of pregnant women to determine
variations in normal magnesium values in the three trimesters of pregnancy.
Background
Amniotic fluid increases in volume as the foetus grows
and peaks at an average of 800 mL at approximately 34
weeks of gestation. Approximately 600 mL of amniotic
fluid surrounds the baby at full term (40 weeks). This
fluid is circulated constantly by the baby inhaling and
swallowing existing fluid and replacing it through exha-
lation and urination [1]. Amniotic fluid accomplishes
numerous functions: (1) it protects the foetus from
injury by cushioning sudden blows or movements, (2) it
enables foetal movement and symmetrical musculoskele-
tal development, (3) it maintains a relatively constant
temperature and thus protects the foetus from heat loss,
and (4) it ensures proper foetal lung development [1,2].
Low levels of magnesium in amniotic fluid are asso-
ciated with pregnancy complications such as preeclamp-
sia [3] and diabetes [4,5]. Magnesium supplements have
been demonstrated to reduce the frequency of delayed
foetal growth, especially in low-birth-weight babies. How-
ever, the general benefits of magnesium for foetal growth
and development have not been demonstrated [6]; the
Magpie study [7], for example, concluded that treatment
with magnesium did not improve preeclampsia.
Consequently, knowledge of the values for this ion in
normal amniotic fluid may p r o v i d eap r e v e n t i v ea n d
early diagnosis of certain maternal and foetal patholo-
gies. Amniocentesis is performed, if indicated, from the
second trimester of pregnancy. Although magnesium
values in amniotic fluid [8-11] are reported in the litera-
ture, no reference values are provided for the three dif-
ferent pregnancy trimesters.
Magnesium in serum is reduced during pregnancy and
so additional magnesium is required in the diet
[6,12,13]. The recommended daily intake for pregnant
w o m e ni sh i g h e rt h a nf o rt h es a m ea g eg r o u po fn o n -
pregnant woman, yet most pregnant women do not con-
sume the required amount [6].
Because variations in magnesium values could be use-
ful as diagnostic and therapeutic guidelines for possible
complications, our aim was to determine magnesium
levels in amniotic fluid so as to establish normal values
for the 14-to-18-week interval of the second trimester of
pregnancy.
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The study design and protocol were reviewed and
approved by the “Ethics Committee of Hospital Univer-
sitario Miguel Servet” in accordance with the Declara-
tion of Helsinki and the Nuremberg Code. All the
patients in the study granted their informed consent.
Included in the study were 92 pregnant women aged
between 21 and 44 years old. Sample size was estab-
lished on the basis of the mean number of pregnant
women undergoing amniocentesis between the 14
th and
18
th week of pregnancy. The average gestational age at
which amniotic fluid samples were obtained by amnio-
centesis was 16.13 (±1.87) weeks. The extracted amnio-
tic fluid samples were sent immediately to the
laboratory for centrifugation and processing to deter-
mine magnesium levels, or, if immediate processing was
not possible, they were stored at -80°C. The reasons for
performing amniocentesis on the patients in our sample
are summarized in Figure 1.
Magnesium levels were analysed for both the amniotic
fluid and serum of the study population, by colorimetric
assay with chlorophosphonazo-III using the Cobas c 501
analyser (Roche Diagnostics). The measurement interval
was 0.24-6.08 mg/dL and the lower detection threshold
was 0.24 mg/dL. The reference serum value for the nor-
mal adult population (21-59 years) was 1.6-2.6 mg/dL.
Statistical analysis was performed using the SPSS pro-
gram, version 15.0.
Results and discussion
Results revealed a mean amniotic fluid value of 1.65 ±
0.16 mg/dL–with the value 1.6 mg/dL repeated in many
samples–and a mean serum value of 1.97 ± 0.23 mg/dL.
Amniotic fluid values for magnesium were slightly lower
than serum values. No variations in magnesium levels
were detected in patients referred for amniocentesis to
diagnose disorders that could imply a risk for the foetus.
Similarly, despite variations in amniotic fluid volume
during pregnancy [1], magnesium concentrations
remained fairly stable.
These results are consistent with previous studies
[8-11] analysing magnesium levels in amniotic fluid;
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Figure 1 Reasons for performing amniocentesis in pregnant women.
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three trimesters of pregnancy.
Falls in amniotic fluid magnesium levels are associated
with pregnancy complications such as preeclampsia [3]
and diabetes [4,5]. Magnesium sulphate, which has a
specific maternal central nervous system anticonvulsant
action, has gained wide international acceptance as an
effective drug for the treatment of eclampsia [14]; how-
ever, magnesium treatment does not appear to be effec-
tive in preventing preeclampsia. Maternal hypoxia and
convulsions, eclampsia and epileptic seizures can have a
neurotoxic effect on the foetus. Magnesium sulphate
may also protect low-birth-weight infants (under 1500
g) against cerebral palsy [15]. Magnesium is also consid-
ered an important factor in the pathogenesis of toxic
shock syndrome; according to one study [15], toxin 1
production by Staphylococcus aureus was maximal when
magnesium concentrations were low, while higher con-
centrations suppressed toxin 1 production. On the other
hand, magnesium sulphate, when given in high dosages
to obstetric patients, can cause significant maternal
morbidity and rare instances of maternal mortality [14].
Conclusions
Despite the risk associated with amniocentesis, it would
be interesting to extend the study to a larger number of
pregnant women and determine magnesium values for
the first, second and third trimesters in both normal
and abnormal pregnancies, so as to establish normal
values and critical ranges and better evaluate complica-
tions and their management.
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